Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 3
Submit an article Journal homepage
155
Views
12
CrossRef citations to date
0
Altmetric
Original

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi

Nicola Di Renzo Unità Operativa di Ematologia ed Oncologia Medica, C.R.O.B., Ospedale Oncologico Regionale, Rionero in Vulture, (PZ), ItalyCorrespondence[email protected]
,
Maura Brugiatelli Divisione di Ematologia, Azienda Ospedaliera Papardo, Messina, Italy
,
Antonella Montanini Dipartimento di Oncologia ed Ematologia, Università di Modena e Reggio Emilia, Modena, Italy
,
Maria Luigia Vigliotti Unità Operativa di Ematologia ed Oncologia Medica, C.R.O.B., Ospedale Oncologico Regionale, Rionero in Vulture, (PZ), Italy
,
Giulia Cervetti Dipartimento di Oncologia Divisione di Ematologia, Az. Ospedaliera Pisana, Ospedale ‘S. Chiara’, Pisa, Italy
,
Anna Marina Liberati Istituto di Medicina Interna e Sc. Oncologiche, Policlinico Monteluce, Perugia, Italy
,
Stefano Luminari Dipartimento di Oncologia ed Ematologia, Università di Modena e Reggio Emilia, Modena, Italy
,
Pierangelo Spedini U.O. di Ematologia, Az. Istituti Ospitalieri, Cremona, Italy
,
Gianfranco Giglio U.O. Semplice di Oncoematologia, Ospedale A. Cardarelli, Campobasso, Italy
&
Massimo Federico Dipartimento di Oncologia ed Ematologia, Università di Modena e Reggio Emilia, Modena, Italy
 show all
Pages 473-479 | Received 16 Jul 2005, Published online: 01 Jul 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.